Reprogramming intratumoral T <sub>reg</sub> cells by morpholino-mediated splicing of FOXP3 for cancer immunotherapy
Yujing Li(University of Science and Technology of China), Xiongbin Lu(The University of Texas MD Anderson Cancer Center)
Cited by 2
Related Papers
PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints
|Genes & Development|2005|383
Bacterial Outer Membrane Vesicles Presenting Programmed Death 1 for Improved Cancer Immunotherapy <i>via</i> Immune Activation and Checkpoint Inhibition
|ACS Nano|2020|271
A T Cell‐Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy
|Advanced Science|2023|55
ST2 as checkpoint target for colorectal cancer immunotherapy
|JCI Insight|2020|52